Old Web
English
Sign In
Acemap
>
authorDetail
>
Oliver von Richter
Oliver von Richter
Medicine
Pharmacokinetics
Internal medicine
Adverse effect
Cmax
4
Papers
78
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54
2019
RMD Open
Rieke Alten
Bogdan Batko
Tomas Hala
Hideto Kameda
Sebastião Cezar Radominski
Vira Tseluyko
Goran Babić
Carol Cronenberger
Sarah Hackley
M.I. Rehman
Oliver von Richter
Min Zhang
Stanley N. Cohen
Show All
Source
Cite
Save
Citations (13)
Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects
2018
Clinical pharmacology in drug development
Dirk Kropeit
Oliver von Richter
Hans‐Peter Stobernack
Helga Rübsamen‐Schaeff
Holger Zimmermann
Show All
Source
Cite
Save
Citations (49)
1